Autor: "Montes BV" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
Autorzy:: Pérez-Belmonte LM; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Avenida de Carlos Haya, s/n, 29010, Málaga, Spain. .
Torres-Peña JD; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
López-Carmona MD; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Avenida de Carlos Haya, s/n, 29010, Málaga, Spain.
Ayala-Gutiérrez MM; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Avenida de Carlos Haya, s/n, 29010, Málaga, Spain.
Fuentes-Jiménez F; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Jorge Huerta L; Internal Medicine Department, 12 de Octubre University Hospital, Madrid, Spain.
Muñoz JA; Internal Medicine Department, Gregorio Marañon University Hospital, Madrid, Spain.
Rubio-Rivas M; Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
Madrazo M; Internal Medicine Department, Dr. Peset University Hospital, Valencia, Spain.
Garcia MG; Internal Medicine Department, San Juan de la Cruz Hospital, Úbeda (Jaén), Spain.
Montes BV; Internal Medicine Department, León University Hospital Complex, León, Spain.
Sola JF; Internal Medicine Department, Clinic Barcelona Hospital, Barcelona, Spain.
Ena J; Internal Medicine Department, Marina Baixa Hospital, Villajoyosa (Alicante), Spain.
Ferrer RG; Internal Medicine Department, Tajo Hospital, Aranjuez (Madrid), Spain.
Pérez CM; Internal Medicine Department, Ferrol University Hospital Complex, Ferrol (A Coruña), Spain.
Ripper CJ; Internal Medicine Department, Insular de Gran Canaria Hospital, Las Palmas de Gran Canaria, Spain.
Lecumberri JJN; Internal Medicine Department, Marqués de Valdecilla University Hospital, Santander, Spain.
Acedo IEA; Internal Medicine Department, Torrecárdenas Hospital, Almería, Spain.
Canteli SP; Internal Medicine Department, Severo Ochoa University Hospital, Leganés (Madrid), Spain.
Cosío SF; Internal Medicine Department, Valle del Nalón Hospital, Riaño (Langreo, Asturias), Spain.
Martínez FA; Internal Medicine Department, Vinalopó University Hospital, Elche (Alicante), Spain.
Rodríguez BC; Internal Medicine Department, Alto Guadalquivir Hospital, Andújar (Jaén), Spain.
Pérez-Martínez P; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain. .; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. .
Ramos-Rincón JM; Department of Clinical Medicine, Miguel Hernandez University of Elche, Alicante, Spain.
Gómez-Huelgas R; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Avenida de Carlos Haya, s/n, 29010, Málaga, Spain.; Pokaż więcej
Corporate Authors:: SEMI-COVID-19 Network
Źródło:: BMC medicine [BMC Med] 2020 Nov 16; Vol. 18 (1), pp. 359. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Coronavirus Infections/*mortality
Diabetes Mellitus, Type 2/*drug therapy
Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use
Hypoglycemic Agents/*standards
Insulin/*therapeutic use
Metformin/*therapeutic use
Pneumonia, Viral/*mortality
Respiration, Artificial/*statistics & numerical data
Sodium-Glucose Transporter 2 Inhibitors/*therapeutic use
Aged ; Aged, 80 and over ; Betacoronavirus ; COVID-19 ; Cohort Studies ; Coronavirus Infections/complications ; Coronavirus Infections/therapy ; Diabetes Mellitus, Type 2/complications ; Drug Therapy, Combination ; Female ; Hospital Mortality ; Hospitalization ; Humans ; Hypoglycemic Agents/therapeutic use ; Intensive Care Units ; Length of Stay/statistics & numerical data ; Logistic Models ; Male ; Noninvasive Ventilation/statistics & numerical data ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/therapy ; Prospective Studies ; SARS-CoV-2 ; Spain

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Montes BV"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język